News from discovery laboratories, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 30, 2015, 07:30 ET

Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury

 Discovery Laboratories, Inc. (Nasdaq: DSCO) today announced that it has received the second $1.0M tranche under a previously awarded Phase II...

Jul 22, 2015, 16:15 ET

Discovery Labs Announces Completion of $40.25 Million Public Offering

Discovery Laboratories, Inc. (NASDAQ: DSCO) today announced that it has completed its previously announced public offering of 16.3 million Series A...

Jul 17, 2015, 08:30 ET

Discovery Labs Announces Pricing of $35 Million Public Offering of Common Stock, Warrants and Pre-funded Warrants

 Discovery Laboratories, Inc. (Nasdaq: DSCO) today announced that it has priced an underwritten public offering of 18.3 Million Series A units...

Jul 16, 2015, 16:01 ET

Discovery Labs Announces Proposed Public Offering of Common Stock, Warrants and Pre-funded Warrants

Discovery Laboratories, Inc. (Nasdaq: DSCO) today announced that it has commenced an underwritten public offering of units.  Each unit will...

Jul 01, 2015, 07:30 ET

Discovery Labs Receives Nasdaq Notification Related to Minimum Bid Price

 Discovery Laboratories, Inc. (Nasdaq: DSCO) announced today that, on June 29, 2015, the Company received a letter from The Nasdaq Stock Market...

May 20, 2015, 07:30 ET

Discovery Labs Announces Enrollment of First Patient in AEROSURF® Phase 2a Dose Expansion Trial

Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for...

May 14, 2015, 07:00 ET

Discovery Labs Announces Results of Phase 2a Clinical Trial of AEROSURF®

 Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for...

May 13, 2015, 11:34 ET

Discovery Labs to Announce Results from AEROSURF® Phase 2a Clinical Trial

 Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for...

May 07, 2015, 16:05 ET

Discovery Labs Reports First Quarter 2015 Financial Results

 Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for...

Apr 16, 2015, 16:15 ET

Discovery Labs Completes Enrollment of AEROSURF® Phase 2a Clinical Trial and Restructures its Business to Focus on Development of AEROSURF® and Aerosolized KL4 Surfactant Pipeline

 Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for...

Mar 16, 2015, 19:41 ET

Discovery Labs Reports Fourth Quarter 2014 Financial Results and Provides Update on SURFAXIN® (lucinactant) Intratracheal Suspension and AEROSURF® Program

 Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology Company dedicated to advancing a new standard in respiratory critical...

Mar 13, 2015, 13:42 ET

Discovery Labs to Hold Conference Call on Tuesday March 17, 2015 to Discuss Fourth Quarter 2014 Financial Results and Other Business Updates

Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care...

Nov 19, 2014, 09:00 ET

Discovery Labs Partners with March of Dimes on 2015 Prematurity Awareness Campaign

In recognition of Prematurity Awareness Month, Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to...

Nov 06, 2014, 07:30 ET

Discovery Labs Reports Third Quarter 2014 Financial Results

 Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical...

Oct 30, 2014, 16:51 ET

Discovery Labs Announces Organizational Change and Enhanced Expertise in Neonatology

Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care,...

Oct 29, 2014, 07:30 ET

Discovery Labs to Report 2014 Third Quarter Financial Results and Hold Conference Call on Thursday, November 6, 2014 at 9:00 a.m. Eastern Time

Discovery Laboratories, Inc. (Nasdaq: DSCO),  a specialty biotechnology company dedicated to advancing a new standard of respiratory critical...

Oct 15, 2014, 07:30 ET

Discovery Labs Announces Strategic Collaboration With Battelle For AEROSURF® Program

 Discovery Laboratories, Inc. (Nasdaq: DSCO) today announced that it has entered into a strategic collaboration with Battelle, the world's...

Oct 01, 2014, 08:00 ET

Discovery Labs Receives SBIR Grant Valued up to $3.0 Million to Support Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury

 Discovery Laboratories, Inc. (Nasdaq: DSCO) today announced that the Company has been awarded a Phase II Small Business Innovation Research...

Aug 05, 2014, 08:15 ET

Discovery Labs Reports Second Quarter 2014 Financial Results

 Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical...

Jul 29, 2014, 11:43 ET

Discovery Labs to Report 2014 Second Quarter Financial Results and Hold Conference Call on Tuesday, August 5, 2014 at 9:00 a.m. Eastern Time

 Discovery Laboratories, Inc. (Nasdaq: DSCO),  a specialty biotechnology company dedicated to advancing a new standard of respiratory...